Who owns Tracon Pharmaceuticals Inc?
- Ticker: TCON
- CUSIP Number: 89237h209
Tip: Access positions for across all investors
Analyze quarterly positions in Tracon Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tracon Pharmaceuticals stock
Who bought or sold Tracon Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 2.8M | $484k | 0% | Dec 2023 |
|
| Squarepoint Ops | 412k | $72k | 100% | Dec 2023 |
|
| Vanguard Group | 263k | $46k | -58% | Dec 2023 |
|
| Millennium Management | 192k | $34k | 100% | Dec 2023 |
|
| CI Private Wealth | 58k | $10k | 0% | Dec 2023 |
|
| Gts Securities | 16k | $2.8k | 100% | Dec 2023 |
|
| HoyleCohen | 13k | $2.3k | 0% | Dec 2023 |
|
| Bank of New York Mellon | 10k | $1.8k | 0% | Dec 2023 |
|
| Game Plan Financial Advisors | 1.0k | $430.000000 | 0% | Mar 2024 |
|
| Royal Bank of Canada | 251.00 | $0 | -5% | Dec 2023 |
|
| Wells Fargo & Company | 204.00 | $36.006000 | 16% | Dec 2023 |
|
Who sold out of Tracon Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Opaleye Management | Sep 2023 | 4.8M | $848k |
| Cutler | Dec 2023 | 1.2k | $0 |